Skip to main content
ACAD
NASDAQ Life Sciences

Acadia-Zydus Nuplazid Patent Fight Ends, RBC Sees Exclusivity to 2038

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$20.065
Mkt Cap
$3.457B
52W Low
$19.566
52W High
$30.96
52W Position info
2.5% above low
Off High info
35% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

ACAD is trading near its 52-week low of $19.566 (2.5% above the low).

Summary

Acadia and Zydus filed a joint stipulation to dismiss all claims in the Nuplazid patent litigation, just weeks before the November 2 trial. RBC says the settlement likely preserves exclusivity through around 2038, removing a key overhang on Acadia's largest revenue driver. Nuplazid is tracking to ~$780M in FY26 sales, near the company's ~$1B peak guidance. This follows prior wins against MSN and Aurobindo, and comes after the remlifanserin Phase 3 miss in September that crushed the stock. The base business now looks overly discounted, and this de-risks Nuplazid's tail revenue.

At the time of this announcement, ACAD was trading at $20.07 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $3.5B. The 52-week trading range was $19.57 to $30.96. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

ACAD - Latest Insights

ACAD
Nov 16, 2026, 1:38 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $18.79
Real-time Price: $17.12 info
Change: -$1.67 (-9%) info
Market Cap: $2.957B info
ACAD
Nov 04, 2026, 6:16 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $21.95
Real-time Price: $17.12 info
Change: -$4.83 (-22%) info
Market Cap: $2.957B info
ACAD
Nov 04, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $21.46
Real-time Price: $17.12 info
Change: -$4.34 (-20%) info
Market Cap: $2.957B info
ACAD
Sep 28, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $20.53
Real-time Price: $17.12 info
Change: -$3.41 (-17%) info
Market Cap: $2.957B info
ACAD
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $20.65
Real-time Price: $17.12 info
Change: -$3.53 (-17%) info
Market Cap: $2.957B info